Pinacidil pretreatrnent extends ischemia tolerance of neonatal rabbit hearts

Jun Feng, Hongling Li, Eliot Rosenkranz

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objectives. Activating ATP-sensitive potassium (K(ATP)) channels improves ischemia tolerance of adult rabbit hearts. We hypothesize that (a) endogenous activation of the K(ATP) channel accounts for better ischemia tolerance of neonatal hearts and (b) exogenous K(ATP) channel activation with pinacidil further improves the neonatal heart's tolerance to cardioplegic ischemia. Methods. Study 1: Seven (control) neonatal rabbits received intraperitoneal saline, whereas five others (Glib) received 0.3 mg/kg glibenclamide 10 min before sacrifice. They were perfused on Langendorff with Krebs-Henseleit buffer (KHB). Baseline left ventricle (LV) performance and coronary flow (CF) were measured. After 20 min of 37°C ischemia and 10 min of reperfusion, recovery was measured. Study 2: Ten (control) neonatal hearts underwent 90 min of normothermic ischemia with St. Thomas' cardioplegia (STCP) solution administered every 30 min. Ten others were pretreated with a 10-min infusion of 1 μM pinacidil in KHB and received 1 μM pinacidil- enriched STCP. Recovery of LV performance and CF were measured after 60 min of reperfusion. Results. Study 1: Glib significantly reduced preischemia LV performance by 28%* compared to control hearts. Recovery of Glib-treated hearts was significantly less (67%*) than controls (81%*). Study 2: Pinacidil-treated hearts had significantly better recovery of LV performance (39%*) and CF (78%*) compared to 23 and 52%, respectively, in untreated controls (*P < 0.05 vs control hearts). Conclusions. Endogenous K(ATP) channel activation in neonatal hearts contributes to their better tolerance to ischemia. Exogenous K(ATP) channel activation by pinacidil pretreatment and cardioplegic enrichment significantly improved the neonatal rabbit heart's tolerance to cardioplegic ischemia. This may be an important addition to myocardial protection during pediatric cardiac surgery. (C) 2000 Academic Press.

Original languageEnglish
Pages (from-to)131-137
Number of pages7
JournalJournal of Surgical Research
Volume90
Issue number2
DOIs
StatePublished - May 15 2000
Externally publishedYes

Fingerprint

Pinacidil
Ischemia
Rabbits
Adenosine Triphosphate
Heart Ventricles
Induced Heart Arrest
Reperfusion
KATP Channels
Glyburide
Thoracic Surgery

Keywords

  • Cardioplegia
  • Ischemia
  • K(ATP) channel
  • Pinacidil

ASJC Scopus subject areas

  • Surgery

Cite this

Pinacidil pretreatrnent extends ischemia tolerance of neonatal rabbit hearts. / Feng, Jun; Li, Hongling; Rosenkranz, Eliot.

In: Journal of Surgical Research, Vol. 90, No. 2, 15.05.2000, p. 131-137.

Research output: Contribution to journalArticle

@article{7354c88d83884574b54b6f60aa17aadf,
title = "Pinacidil pretreatrnent extends ischemia tolerance of neonatal rabbit hearts",
abstract = "Objectives. Activating ATP-sensitive potassium (K(ATP)) channels improves ischemia tolerance of adult rabbit hearts. We hypothesize that (a) endogenous activation of the K(ATP) channel accounts for better ischemia tolerance of neonatal hearts and (b) exogenous K(ATP) channel activation with pinacidil further improves the neonatal heart's tolerance to cardioplegic ischemia. Methods. Study 1: Seven (control) neonatal rabbits received intraperitoneal saline, whereas five others (Glib) received 0.3 mg/kg glibenclamide 10 min before sacrifice. They were perfused on Langendorff with Krebs-Henseleit buffer (KHB). Baseline left ventricle (LV) performance and coronary flow (CF) were measured. After 20 min of 37°C ischemia and 10 min of reperfusion, recovery was measured. Study 2: Ten (control) neonatal hearts underwent 90 min of normothermic ischemia with St. Thomas' cardioplegia (STCP) solution administered every 30 min. Ten others were pretreated with a 10-min infusion of 1 μM pinacidil in KHB and received 1 μM pinacidil- enriched STCP. Recovery of LV performance and CF were measured after 60 min of reperfusion. Results. Study 1: Glib significantly reduced preischemia LV performance by 28{\%}* compared to control hearts. Recovery of Glib-treated hearts was significantly less (67{\%}*) than controls (81{\%}*). Study 2: Pinacidil-treated hearts had significantly better recovery of LV performance (39{\%}*) and CF (78{\%}*) compared to 23 and 52{\%}, respectively, in untreated controls (*P < 0.05 vs control hearts). Conclusions. Endogenous K(ATP) channel activation in neonatal hearts contributes to their better tolerance to ischemia. Exogenous K(ATP) channel activation by pinacidil pretreatment and cardioplegic enrichment significantly improved the neonatal rabbit heart's tolerance to cardioplegic ischemia. This may be an important addition to myocardial protection during pediatric cardiac surgery. (C) 2000 Academic Press.",
keywords = "Cardioplegia, Ischemia, K(ATP) channel, Pinacidil",
author = "Jun Feng and Hongling Li and Eliot Rosenkranz",
year = "2000",
month = "5",
day = "15",
doi = "10.1006/jsre.2000.5865",
language = "English",
volume = "90",
pages = "131--137",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Pinacidil pretreatrnent extends ischemia tolerance of neonatal rabbit hearts

AU - Feng, Jun

AU - Li, Hongling

AU - Rosenkranz, Eliot

PY - 2000/5/15

Y1 - 2000/5/15

N2 - Objectives. Activating ATP-sensitive potassium (K(ATP)) channels improves ischemia tolerance of adult rabbit hearts. We hypothesize that (a) endogenous activation of the K(ATP) channel accounts for better ischemia tolerance of neonatal hearts and (b) exogenous K(ATP) channel activation with pinacidil further improves the neonatal heart's tolerance to cardioplegic ischemia. Methods. Study 1: Seven (control) neonatal rabbits received intraperitoneal saline, whereas five others (Glib) received 0.3 mg/kg glibenclamide 10 min before sacrifice. They were perfused on Langendorff with Krebs-Henseleit buffer (KHB). Baseline left ventricle (LV) performance and coronary flow (CF) were measured. After 20 min of 37°C ischemia and 10 min of reperfusion, recovery was measured. Study 2: Ten (control) neonatal hearts underwent 90 min of normothermic ischemia with St. Thomas' cardioplegia (STCP) solution administered every 30 min. Ten others were pretreated with a 10-min infusion of 1 μM pinacidil in KHB and received 1 μM pinacidil- enriched STCP. Recovery of LV performance and CF were measured after 60 min of reperfusion. Results. Study 1: Glib significantly reduced preischemia LV performance by 28%* compared to control hearts. Recovery of Glib-treated hearts was significantly less (67%*) than controls (81%*). Study 2: Pinacidil-treated hearts had significantly better recovery of LV performance (39%*) and CF (78%*) compared to 23 and 52%, respectively, in untreated controls (*P < 0.05 vs control hearts). Conclusions. Endogenous K(ATP) channel activation in neonatal hearts contributes to their better tolerance to ischemia. Exogenous K(ATP) channel activation by pinacidil pretreatment and cardioplegic enrichment significantly improved the neonatal rabbit heart's tolerance to cardioplegic ischemia. This may be an important addition to myocardial protection during pediatric cardiac surgery. (C) 2000 Academic Press.

AB - Objectives. Activating ATP-sensitive potassium (K(ATP)) channels improves ischemia tolerance of adult rabbit hearts. We hypothesize that (a) endogenous activation of the K(ATP) channel accounts for better ischemia tolerance of neonatal hearts and (b) exogenous K(ATP) channel activation with pinacidil further improves the neonatal heart's tolerance to cardioplegic ischemia. Methods. Study 1: Seven (control) neonatal rabbits received intraperitoneal saline, whereas five others (Glib) received 0.3 mg/kg glibenclamide 10 min before sacrifice. They were perfused on Langendorff with Krebs-Henseleit buffer (KHB). Baseline left ventricle (LV) performance and coronary flow (CF) were measured. After 20 min of 37°C ischemia and 10 min of reperfusion, recovery was measured. Study 2: Ten (control) neonatal hearts underwent 90 min of normothermic ischemia with St. Thomas' cardioplegia (STCP) solution administered every 30 min. Ten others were pretreated with a 10-min infusion of 1 μM pinacidil in KHB and received 1 μM pinacidil- enriched STCP. Recovery of LV performance and CF were measured after 60 min of reperfusion. Results. Study 1: Glib significantly reduced preischemia LV performance by 28%* compared to control hearts. Recovery of Glib-treated hearts was significantly less (67%*) than controls (81%*). Study 2: Pinacidil-treated hearts had significantly better recovery of LV performance (39%*) and CF (78%*) compared to 23 and 52%, respectively, in untreated controls (*P < 0.05 vs control hearts). Conclusions. Endogenous K(ATP) channel activation in neonatal hearts contributes to their better tolerance to ischemia. Exogenous K(ATP) channel activation by pinacidil pretreatment and cardioplegic enrichment significantly improved the neonatal rabbit heart's tolerance to cardioplegic ischemia. This may be an important addition to myocardial protection during pediatric cardiac surgery. (C) 2000 Academic Press.

KW - Cardioplegia

KW - Ischemia

KW - K(ATP) channel

KW - Pinacidil

UR - http://www.scopus.com/inward/record.url?scp=0034656418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034656418&partnerID=8YFLogxK

U2 - 10.1006/jsre.2000.5865

DO - 10.1006/jsre.2000.5865

M3 - Article

VL - 90

SP - 131

EP - 137

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 2

ER -